TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

Highlights

• Newly granted patent protects TempraMed's VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architecture
• Expands the Company's ability to adapt its core technology to a wider range of drug categories-from chronic self-injectables to complex biologics
• Enhances commercialization opportunities and supports strategic engagement with leading appliance manufacturers in Asia's premium refrigeration market

Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has been granted an additional allowed patent in South Korea, issued under Korean Patent Application No. 10-2021-7011422.

The newly granted patent covers, among other features, the Company's new product category, VIVI Box™, a consumer-focused medical-storage system engineered to keep temperature-sensitive medications safe within domestic refrigerators. The system prevents freezing, stabilizes medication temperatures, and maintains a secure 8°C environment for up to 24 hours without external power. VIVI Box™ provides uninterrupted protection during routine use, travel, transportation, or unexpected power outages. Designed to support fast-growing medication categories including insulin, GLP-1 therapies, biologics, and other specialty drugs, VIVI Box™ offers a dependable, reusable solution that bridges the gap between pharmacy cold-chain requirements and real-world patient behavior.

Without limiting the scope of the patent, it includes capabilities such as:

• Continuous temperature protection during power interruptions or refrigerator temperature fluctuations
• A portable, all-day travel solution for users requiring secure on-the-go cold storage
• Smart content tracking with cloud-based data integration to support adherence and remote monitoring

These capabilities position VIVI Box™ as a differentiated platform at the intersection of home health, smart refrigeration, and the consumer IoT medical-device ecosystem. The invention advances TempraMed's strategy to evolve beyond single-injection protection into multi-dose, multi-format medication-storage systems—core components of the Company's long-term commercialization plan.